Van Linthout S, Stellos K, Giacca M, Bertero E, Cannata A, Carrier L
Eur J Heart Fail. 2024; 27(1):5-25.
PMID: 39576264
PMC: 11798634.
DOI: 10.1002/ejhf.3516.
Scott S, Westhaus A, Nazareth D, Cabanes-Creus M, Navarro R, Chandra D
Mol Ther Methods Clin Dev. 2024; 32(4):101351.
PMID: 39498467
PMC: 11532298.
DOI: 10.1016/j.omtm.2024.101351.
Wu G, Liu S, Hagenstein J, Alawi M, Hengel F, Schaper M
J Clin Invest. 2024; 134(17).
PMID: 39225099
PMC: 11364381.
DOI: 10.1172/JCI174722.
Li L, Qin R, Liu Y, Tseng Y, Zhang W, Yu L
PLoS Pathog. 2024; 20(6):e1012260.
PMID: 38885242
PMC: 11182496.
DOI: 10.1371/journal.ppat.1012260.
Lu Y, Ling C, Shoti J, Yang H, Nath A, Keeler G
Mol Ther Nucleic Acids. 2024; 35(2):102196.
PMID: 38766527
PMC: 11101737.
DOI: 10.1016/j.omtn.2024.102196.
New AAV9 engineered variants with enhanced neurotropism and reduced liver off-targeting in mice and marmosets.
Giannelli S, Luoni M, Iannielli A, Middeldorp J, Philippens I, Bido S
iScience. 2024; 27(5):109777.
PMID: 38711458
PMC: 11070337.
DOI: 10.1016/j.isci.2024.109777.
Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights.
Lopez-Gordo E, Chamberlain K, Riyad J, Kohlbrenner E, Weber T
Viruses. 2024; 16(3).
PMID: 38543807
PMC: 10975205.
DOI: 10.3390/v16030442.
Use of adeno-associated viruses for transgenic modulation of microglia structure and function: A review of technical considerations and challenges.
Ball J, Frank M, Green-Fulgham S, Watkins L
Brain Behav Immun. 2024; 118:368-379.
PMID: 38471576
PMC: 11103248.
DOI: 10.1016/j.bbi.2024.03.005.
Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6.
Hohne K, Wagenknecht A, Maier C, Engelhard P, Goldmann T, Schliessmann S
Cells. 2024; 13(3.
PMID: 38334630
PMC: 10854834.
DOI: 10.3390/cells13030238.
Optimal trade-off control in machine learning-based library design, with application to adeno-associated virus (AAV) for gene therapy.
Zhu D, Brookes D, Busia A, Carneiro A, Fannjiang C, Popova G
Sci Adv. 2024; 10(4):eadj3786.
PMID: 38266077
PMC: 10807795.
DOI: 10.1126/sciadv.adj3786.
An AAV capsid reprogrammed to bind human Transferrin Receptor mediates brain-wide gene delivery.
Huang Q, Chan K, Lou S, Keyes C, Wu J, Botticello-Romero N
bioRxiv. 2024; .
PMID: 38187643
PMC: 10769326.
DOI: 10.1101/2023.12.20.572615.
Multiparametric domain insertional profiling of adeno-associated virus VP1.
Hoffmann M, Zdechlik A, He Y, Nedrud D, Aslanidi G, Gordon W
Mol Ther Methods Clin Dev. 2023; 31:101143.
PMID: 38027057
PMC: 10661864.
DOI: 10.1016/j.omtm.2023.101143.
Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy.
Srivastava A
Mol Ther Nucleic Acids. 2023; 32:949-959.
PMID: 37293185
PMC: 10244667.
DOI: 10.1016/j.omtn.2023.05.014.
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?.
Ail D, Malki H, Zin E, Dalkara D
Appl Clin Genet. 2023; 16:111-130.
PMID: 37274131
PMC: 10239239.
DOI: 10.2147/TACG.S383453.
Every little bit helps: A single-residue switch in a vascular AAV enables blood-brain barrier penetration.
Grimm D, Nonnenmacher M
Mol Ther Methods Clin Dev. 2023; 29:364-365.
PMID: 37214312
PMC: 10199398.
DOI: 10.1016/j.omtm.2023.04.007.
Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino R, Wang Q, Xu H, Hu G, Bell P, Arroyo E
J Virol. 2023; 97(6):e0017423.
PMID: 37199615
PMC: 10308920.
DOI: 10.1128/jvi.00174-23.
Improving retinal vascular endothelial cell tropism through rational rAAV capsid design.
Periasamy R, Patel D, Boye S, Boye S, Lipinski D
PLoS One. 2023; 18(5):e0285370.
PMID: 37167304
PMC: 10174500.
DOI: 10.1371/journal.pone.0285370.
Computer-Aided Directed Evolution Generates Novel AAV Variants with High Transduction Efficiency.
Han Z, Luo N, Wang F, Cai Y, Yang X, Feng W
Viruses. 2023; 15(4).
PMID: 37112829
PMC: 10143561.
DOI: 10.3390/v15040848.
A blood-brain barrier-penetrating AAV2 mutant created by a brain microvasculature endothelial cell-targeted AAV2 variant.
Kawabata H, Konno A, Matsuzaki Y, Hirai H
Mol Ther Methods Clin Dev. 2023; 29:81-92.
PMID: 36970652
PMC: 10036519.
DOI: 10.1016/j.omtm.2023.02.016.
AAV Engineering for Improving Tropism to the Central Nervous System.
Ghauri M, Ou L
Biology (Basel). 2023; 12(2).
PMID: 36829465
PMC: 9953251.
DOI: 10.3390/biology12020186.